Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Prateek has more than 23 years of rich experience in Human Resource
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Subscribe To Our Newsletter & Stay Updated
